Updated Review of Major Cancer Risk Factors and Screening Test Use in the United States, with a Focus on Changes During the COVID-19 Pandemic.
Jessica StarPriti BandiNigar NargisFarhad IslamiK Robin YabroffAdair K MinihanRobert A SmithAhmedin JemalPublished in: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2023)
We present national and state representative prevalence estimates of modifiable cancer risk factors, preventive behaviors and services, and screening, with a focus on changes during the COVID-19 pandemic. Between 2019 and 2021, current smoking, physical inactivity, and heavy alcohol consumption declined, and human papillomavirus vaccination and stool testing for colorectal cancer screening uptake increased. In contrast, obesity prevalence increased, while fruit consumption and cervical cancer screening declined during the same timeframe. Favorable and unfavorable trends were evident during the 2nd year of the COVID-19 pandemic that must be monitored as more years of consistent data are collected. Yet disparities by racial/ethnic and socioeconomic status persisted, highlighting the continued need for interventions to address suboptimal levels among these population subgroups.
Keyphrases
- risk factors
- alcohol consumption
- papillary thyroid
- physical activity
- colorectal cancer screening
- mental health
- healthcare
- squamous cell
- insulin resistance
- cervical cancer screening
- type diabetes
- metabolic syndrome
- primary care
- magnetic resonance
- electronic health record
- weight loss
- squamous cell carcinoma
- quality improvement
- machine learning
- big data
- deep learning
- smoking cessation
- health insurance